Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

DoubleLine Equity Healthcare Fund

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 1
Average round size
info
The average size of a deal this fund participated in
$75M
Portfolio companies 1
Lead investments 0
Exits 1
Key employees Soon

Areas of investment

  • Biopharma
  • Health Care
  • Biotechnology
Summary

The top amount of exits for fund were in 2017. The fund is constantly included in less than 2 deals per year. The usual things for fund are deals in the range of 50 - 100 millions dollars. The high activity for fund was in 2015.

Among the most popular portfolio startups of the fund, we may highlight Ovid Therapeutics. We can highlight the next thriving fund investment areas, such as Health Care, Biotechnology. Besides, a startup requires to be at the age of 1 and less years to receive the investment from the fund.

The usual cause for the fund is to invest in rounds with 8 partakers. The meaningful sponsors for the fund in investment in the same round are Tekla Capital Management, Sphera Funds Management, Sanofi-Genzyme BioVentures.

Read more

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Alfa Ventures Delhi, Delhi, India
Enlight Media Beijing, Beijing, China
Equity Resources Group Cambridge, Massachusetts, United States
Harbin Yungu Venture Capital Enterprise China, Harbin, Heilongjiang
Huihua Investment China, Fenghua, Zhejiang
Kerun Chuangtou China, Shanghai
Livzon Pharmaceutical Group China, Guangdong, Zhuhai
NXT Capital Chicago, Illinois, United States
Qicheng Chuang Tou China, Dongguan, Hebei
Qixi Capital -
Quintus Vermoegensverwaltung GmbH -
Starboard Value New York, New York, United States
Startup:Education New Jersey, Newark, United States
Stokke Industri -
UniCredit EVO Italy, Lombardia, Milano
Velos Partners California, Los Angeles, United States
Viscogliosi Brothers New York, New York, United States
Westcott LLC Dallas, Texas, United States
ZJKF Capital Management China, Hangzhou, Zhejiang

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Ovid Therapeutics

Biopharma
Biotechnology
Health Care
$75M11 Aug 2015 New York, New York, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent DoubleLine Equity Healthcare Fund?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 1
Average round size 75M
Peak activity year 2015
Lead investments 0
Exits 1
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Ovid Therapeutics

Biopharma
Biotechnology
Health Care
$75M11 Aug 2015 New York, New York, United States
Crunchbase icon

Content report

The following text will be sent to our editors: